SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-007361
Filing Date
2019-06-07
Accepted
2019-06-07 17:47:10
Documents
2
Period of Report
2019-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1677
2 POWER OF ATTORNEY poahindman.txt EX-24 3386
  Complete submission text file 0001179110-19-007361.txt   6474
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ACORDA THERAPEUTICS, INC. 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address
Hindman Andrew A. (Reporting) CIK: 0001607965 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36033 | Film No.: 19887045